Powering tissue factories

We make tissue manufacturing reproducible at every scale, from a single bench to autonomous labs.

WITHIN TOLERANCE Human tissue model Site ASite BSite C Capitula: one platform across every step

Demand for human tissue models is growing fast

Drug developers and clinical teams need human tissue, not animal proxies, at production volume. The field is accelerating toward better preclinical models.

  1. 2019EPA · plan to end mammal testing by 2035
  2. 2021EU Parliament · resolution to phase out animal testing
  3. 2022FDA Modernization Act 2.0
  4. 2025FDA · Roadmap to Reducing Animal Testing
  5. 2025NIH · prioritizing non-animal methods
  6. 2026EU · Roadmap to phase out animal testing in chemical safety
  7. In progressFDA Modernization Act 3.0

The tools were built for experiments, not manufacturing

Today the data doesn't connect. Build instructions, paper notebooks, bioink logs, quality analysis, and assay results live in separate tools, so they're difficult to search, communicate, and reproduce.

Paper notebook Build instructions Quality analysis Assay results Bioink & process log No shared record

Now every step writes to the same record

Five modules cover the workflow, coordinate to predict. Each one replaces a manual step that used to end in a file nobody else could open, and each writes to the same structured record instead.

One connected record Cosmos BioSlicer Calendula Helianthus Solidago

Drug discovery has been here before

After the 1962 Kefauver-Harris Amendment raised the evidentiary bar, the industry reorganized around structured, reproducible data. High-throughput screening was built on that foundation: standardized compound libraries and consistent records to screen against.

1962 2022 Safety and efficacy Animal testing mandate lifted Kefauver-Harris Structured records HTS In silico models FDA Modernization Structured records Preclinical models In silico models

We are on the verge of a preclinical model revolution, and like the last one it will be built on a structured record of every design, process and result.

Reproducibility makes manufacturing possible

Capitula spans the whole workflow, from preparation through analysis.

CAPITULA Preparation Biofabricator Analysis

Start standardizing your workflow now

Scaled tissue manufacturing starts with reproducible data, and that starts with your next build. Capitula is built and shipping now.

Explore CapitulaContact us